Collectively, these findings demonstrate that decreased GSH content and reduced Gpx4 levels lead to redox imbalance, targeting this redox homeostasis pathway could help alleviate ferroptosis-related damage in AD. This evidence concerns the gene GPX4 and Alzheimer disease.